Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer-Reference-Cited by-同舟云学术

Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)–Positive Metastatic Breast Cancer

Published:2017-01-03 Issue:1 Volume:317 Page:37
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Rugo Hope S.¹,Barve Abhijit²,Waller Cornelius F.³,Hernandez-Bronchud Miguel⁴,Herson Jay⁵,Yuan Jinyu⁶,Sharma Rajiv⁶,Baczkowski Mark⁶,Kothekar Mudgal⁷,Loganathan Subramanian⁷,Manikhas Alexey⁸,Bondarenko Igor⁹,Mukhametshina Guzel¹⁰,Nemsadze Gia¹¹,Parra Joseph D.¹²,Abesamis-Tiambeng Maria Luisa T.¹³,Baramidze Kakhaber¹⁴,Akewanlop Charuwan¹⁵,Vynnychenko Ihor¹⁶,Sriuranpong Virote¹⁷,Mamillapalli Gopichand¹⁸,Ray Sirshendu¹⁹,Yanez Ruiz Eduardo P.²⁰,Pennella Eduardo⁶,

Affiliation:

1. University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco

2. Biocon Research Limited, Bangalore, India3Now with Mylan Inc, Canonsburg, Pennsylvania

3. Department of Haematology, Oncology, and Stem Cell Transplantation, University Medical Centre Freiburg and Faculty of Medicine, University of Freiburg, Freiburg, Germany

4. Quiron-Dexeus, Barcelona, Spain

5. Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland

6. Mylan Inc, Canonsburg, Pennsylvania

7. Biocon Research Limited, Bangalore, India

8. City Clinical Oncology Dispensary, Saint Petersburg, Russia

9. Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine

10. Regional Clinical Oncological Center, Kazan, Russia

11. Institute of Clinical Oncology, Tbilisi, Georgia

12. St Luke’s Medical Center Global City, Taguig City, Philippines

13. Cardinal Santos Medical Center, Manila, Philippines

14. Golden Fleece 21 Century Health House Ltd, Tbilisi, Georgia

15. Siriraj Hospital, Bangkok, Thailand